Marc J. Kahn, MD, MBA
Hematology/Medical Oncology
Marc J. Kahn, MD, MBA, is the division chief of the Hematology/Medical Oncology section in the Department of Medicine at the Kirk Kerkorian School of Medicine. Dr. Kahn was previously the dean of the Kirk Kerkorian School of Medicine and vice president for health affairs at UNLV for five years. Dr. Kahn completed his undergraduate and medical school training at the University of Pennsylvania where he graduated summa cum laude and was elected into Alpha Omega Alpha. He then went on to complete his internal medicine residency, chief medical residency, and hematology/medical oncology fellowship at the Hospital of the University of Pennsylvania. Dr. Kahn obtained his master’s in business administration with honors from the AB Freeman School of Business at Tulane in 2010.
Dr. Kahn has held multiple leadership positions nationally including serving on the Hematology Governing Board of the American Board of Internal Medicine, serving on the board of the National Residency Matching Program, serving multiple leadership positions with the Association of American Medical Colleges, serving as a member of the Liaison Committee on Medical Education, serving leadership positions with the American Society of Hematology, and being chosen as a Master of the American College of Physicians. In 2019, Dr. Kahn was one of only a few physicians not trained in the United Kingdom to be elected as a fellow of the Royal College of Physicians of London, the oldest medical college in England.
A prolific researcher in benign hematology, medical education, and healthcare finance. Dr. Kahn has authored over 100 peer-reviewed manuscripts in addition to over 140 book chapters and six books. His most recent book, Business of Building and Managing a Healthcare Practice, was published by Springer Nature in early 2023 and is currently being updated for a third edition. To view some of Dr. Kahn’s publications, visit PubMed.
Dr. Kahn is passionate about caring for the Las Vegas community through education, research, clinical care, and community engagement. He is anxious to create an academic division of hematology/medical oncology. He believes the creation of such a division within an academic health center in Southern Nevada will provide accessible and compassionate cancer care while creating jobs and growing the Las Vegas economy.